Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

NCT: NCT07070115 · RECRUITING

NCT IDNCT07070115
StatusRECRUITING
Start Date2025-07-25
Completion2032-07-31
SponsorTela Bio Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.

Frequently Asked Questions

What is Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®?

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® is a clinical trial registered under NCT07070115. Current status: RECRUITING.

What is the status of NCT07070115?

The current status of NCT07070115 (Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®) is: RECRUITING.

When did Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® start?

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® started on 2025-07-25.

Related Devices

K214070OviTex PRS (Long Term Resorbable)Tela Bio K243595OviTex PRS (Long-Term Resorbable)TELA Bio, Inc. K241126OviTex PRSTELA Bio, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑